Effective treatment of fibrillation
Articles
-
12 / August 2023MODERN OPPORTUNITIES FOR TREATMENT OF PATIENT HAVING CHRONIC HEART FAILURE WITH LOW EJECTION FRACTION
Worldwide, the prevalence of chronic heart failure (CHF) is increasing every year, representing a serious medical and social problem. Medicinal drugs can help manage the symptoms of CHF and improve…
-
12 / August 2023ENDOVASCULAR OCCLUSION OF THE PATENT FORAMEN OVALE AS PART OF ANTIARRHYTHMIC TREATMENT OF A PATIENT WITH PERSISTENT ATRIAL FIBRILLATION (CASE REPORT)
Below is a case report of treatment of a patient with persistent tachysystolic atrial fibrillation (AF), chronic heart failure (CHF) with a moderately reduced left ventricular ejection fraction (EF) and…
-
12 / August 2022Endocardial Electrophysiological Study in Clinical Practice in Patients with Bradysystole and Conduction Rhythm Disorders: a review
The article demonstrates modern diagnostic capabilities of endocardial electrophysiological examination in cardiological patients with bradysystole and conduction disturbances that allow adequate assessment of the clinical situation. We made an attempt…
-
12 / August 2022Non-Invasive Electrophysiological Markers Associated With Long QT Syndrome
Long QT syndrome (LQTS) is a life-threatening channelopathy, characterized by permanent or transient QT interval prolongation on the 12-lead electrocardiogram and syncope associated with malignant ventricular rhythm disturbances, particularly polymorphic…
-
12 / August 2021Postabaltive Pericarditis in Patient with a Prior History of Rheumatic Disease: a Case Report
A 60 year-old male with a previous (40 years ago) history of rheumatic carditis without valve involvement and 5 years history of paroxysmal atrial fibrillation underwent ablation (PV isolation with…
-
29 / December 2019
Research: International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
Read the Research “International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)”. Abstract Background: Real-world data on non-vitamin K oral…